An interventional study of Exercise plus nutrition and Exercise in Subjective Cognitive Decline and Age-Related Cognitive Decline, sponsored by Rotman Research Institute at Baycrest. Terminated at 4 sites in Canada. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-10-14.
Sponsored by Rotman Research Institute at Baycrest · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study will explore the impact of an exercise and nutrition (EX+NUTR) , relative to exercise alone (EX) intervention, on brain structure and function as well as blood biomarkers in older adults with subjective cognitive decline (SCD) and vascular risk factors. The overall hypotheses are that a combined EX+NUTR, relative to EX, intervention will evoke more positive changes in brain structure (e.g. hippocampal volume), neural activity (e.g. task associated functional activations monitored through fMRI), and cognitive performance. These changes will be associated with an improved metabolic profile, reductions in inflammatory cytokines and oxidative burden, and greater intervention compliance.
All participants will engage in group supervised exercise sessions once per week as well as engage in additional exercise sessions at home 4 days/week. The exercise program will be run out of two sites (Toronto Rehabilitation Institute (TRI) - Rumsey Centre in Toronto, and the Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo). The supervised exercise sessions modeled after the standard TRI Cardiovascular Prevention and Rehabilitation program, including aerobic training, resistance training and education/counseling. The active group will receive strategy training to simultaneously improve their diet in conjunction with our newly developed Brain Health Food Guide (EX+BHFG); the placebo control group (EX+BHEd) will receive brain health education to control for time and social participation. [NOTE All participants must also be enrolled in the SCD cohort of the CCNA and undergo the CCNA's COMPASS-ND assessment at the beginning of the trial.] The study is 6 months in duration and requires participants to attend 2.5 hr weekly sessions (1 hr supervised exercise, 0.5 hr exercise/stress education and 1 hr nutrition or brain health education) and to exercise on their own an additional 3-4 times per week. Participants are assessed on measures of cognition, brain health (MRI), functional status at baseline, post intervention and 6 month follow-up.
Rotman Research Institute at Baycrest is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
meeting criteria for subjective cognitive impairment (1 through 5 below)
Answer Yes to both following questions:
Have a delayed recall score on 1 paragraph of the Logical Memory test (Wechsler Memory Scale, maximum score 25) above the education-adjusted cut-offs:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
6 months of supervised group exercise plus education and strategy training to alter diet to be consistent with recommendations outlined in our brain health food guide (BHFG).
Behavioral: Exercise plus nutrition
Identical exercise to the experimental plus education and passive discussion about brain health and healthy lifestyle to control for experimental group nutrition sessions.
Behavioral: Exercise
On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.
Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Changes from baseline brain structure at 6 months and 12 months.
Cortical and subcortical grey matter density using MRI three-dimensional T1 weighted structural scan (MPRAGE)
Time frame: 6 months plus 6 month follow-up
Changes from baseline cerebral blood flow at 6 months and 12 months.
Pseudo-continuous arterial spin labeling MRI (pcASL) to quantify cerebral blood flow
Time frame: 6 months plus 6 month follow-up
Changes from baseline cognition at 6 months and 12 months
pen and paper and computerized tasks, monitoring memory, executive function, and speed of processing. The results will be presented as a composite score of total neuro-psychological performance aggregating scores from the above cognitive domains.
Time frame: 6 months plus 6 month follow-up
Changes from baseline brain activity related to attention at 6 months and 12 months
BOLD functional MRI while participants performing an attention task
Time frame: 6 months plus 6 month follow-up
Changes from baseline resting state connectivity at 6 months and 12 months
BOLD functional MRI while participants at rest
Time frame: 6 months plus 6 month follow-up
Changes from baseline diet quality at 6 months and 12 months
Principle component analyses based on Canadian Diet History Questionnaire II (C-DHQII)
Time frame: 6 months plus 6 month follow-up
Changes from baseline adherence to diet recommendations at 6 months and 12 months
Principle component analyses based on the Eating Pattern Self-Assessment
Time frame: 6 months plus 6 month follow-up
Changes from baseline grip strength at 6 months and 12 months
Grip strength using a hand held dynamometer
Time frame: 6 months plus 6 month follow-up
Changes from baseline gait performance at 6 months and 12 months
Gait velocity, stride length/width, and associated variability assessed using a GAITRite pressure sensor mat.
Time frame: 6 months plus 6 month follow-up
Changes from baseline balance performance at 6 months and 12 months
Posturography assessment on balance platform
Time frame: 6 months plus 6 month follow-up
Changes from baseline maximal oxygen uptake at 6 months and 12 months
VO2max determined during cardiopulmonary assessment
Time frame: 6 months plus 6 month follow-up
Changes from baseline blood moderators at 6 months and 12 months
e.g. BDNF, pro-BDNF, ApoE,
Time frame: 6 months plus 6 month follow-up
Changes from baseline HbA1C at 6 months and 12 months
HbA1C
Time frame: 6 months plus 6 month follow-up
Changes from baseline fasting glucose at 6 months and 12 months
fasting glucose
Time frame: 6 months plus 6 month follow-up
Changes from baseline insulin levels at 6 months and 12 months
insulin
Time frame: 6 months plus 6 month follow-up
Changes from baseline lipid levels at 6 months and 12 months
lipid profile
Time frame: 6 months plus 6 month follow-up
Changes from baseline homocysteine levels at 6 months and 12 months
homocysteine
Time frame: 6 months plus 6 month follow-up
Changes from baseline C reactive protein levels at 6 months and 12 months
CRP
Time frame: 6 months plus 6 month follow-up
Changes from baseline TNF-alpha levels at 6 months and 12 months
TNF-alpha
Time frame: 6 months plus 6 month follow-up
Changes from baseline IL6 levels at 6 months and 12 months
IL6
Time frame: 6 months plus 6 month follow-up
Changes from baseline vitamin K levels at 6 months and 12 months
Vitamin K
Time frame: 6 months plus 6 month follow-up
Plan to share: Yes — data will be uploaded to shared CCNA database - LORIS
Ran from Jul 2018 to primary completion in Oct 2020, 27 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rotman Research Institute at Baycrest